CXCL13 rs355687 variant confers increased susceptibility to systemic lupus erythematosus in a Mexican population
Open Access
- 29 October 2026
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 59 (1)
Abstract
Chemokines are a family of structurally related, low-molecular-weight proteins (8–14 kDa) that regulate leukocyte recruitment under both homeostatic and pathological conditions, including infection...Keywords
This publication has 38 references indexed in Scilit:
- CXCL13: a common target for immune-mediated inflammatory diseasesClinical and Experimental Medicine, 2024
- Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk LocusArthritis & Rheumatology, 2023
- A review on the role of chemokines in the pathogenesis of systemic lupus erythematosusCytokine, 2021
- The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activityClinical and Experimental Medicine, 2021
- CXCL13/CXCR5 signaling axis in cancerLife Sciences, 2019
- Immunological pathogenesis and treatment of systemic lupus erythematosusWorld Journal of Pediatrics, 2019
- CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort studyArchives of Dermatological Research, 2018
- A functional SNP MCP-1 (−2518A/G) predispose to renal disorder in Indian Systemic Lupus Erythematosus patientsCytokine, 2017
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis & Rheumatism, 2012
- HUMAN B CELL-ATTRACTING CHEMOKINE 1 (BCA-1; CXCL13) IS AN AGONIST FOR THE HUMAN CXCR3 RECEPTORCytokine, 2001